Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, Kaptoge S, Ballantyne C, Cannon CP, Criqui M, Cushman M, et al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010  ;375(9725):1536-44.

Seshasai SRao Kondap, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011  ;364(9):829-841.

Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, et al. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012  ;307(23):2499-506.

Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Seshasai SRao Kondap, Thompson A, Sarwar N, Willeit P, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014  ;311(12):1225-33.

Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O'Keeffe LM, Gao P, Wood AM, Burgess S, et al. Association of Cardiometabolic Multimorbidity With Mortality. JAMA. 2015  ;314(1):52-60.

Willeit P, Kaptoge S, Welsh P, Butterworth A, Chowdhury, iv R, Spackman S, Pennells L, Gao P, Burgess S, Freitag D, et al. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol. 2016  ;4(10):840-9.